Inhibitors for the mutagenicities of colon carcinogens, 1,2-dimethylhydrazine and azoxymethane, in the host-mediated assay. 1979

M Moriya, and T Ohta, and K Watanabe, and Y Watanabe, and F Sugiyama, and T Miyazawa, and Y Shirasu

Inhibitory effects of several chemicals on the mutagenicities of 1,2-dimethylhydrazine (DMH) and azoxymethane (AOM) for Salmonella typhimurium G46 in the host-mediated assay were investigated. They were carbon disulfide (CS2), tetraethylthiuram disulfide (disulfiram, DSF), sodium diethyldithiocarbamate (SDDC), ethylene-bis(dithiocarbamato) manganese (Maneb), pyrazole (PZ), aminoacetonitrile hydrogen sulfate (AAN), and sodium selenite (SE). All the compounds, except for SE, inhibited the mutagenicities of DMH and AOM.

UI MeSH Term Description Entries
D008297 Male Males
D008344 Maneb Manganese derivative of ethylenebisdithiocarbamate. It is used in agriculture as a fungicide and has been shown to cause irritation to the eyes, nose, skin, and throat. Manganese, ((1,2-ethanediylbis(carbamodithioato))(2-))-
D008763 Methylhydrazines Hydrazines substituted by one or more methyl groups in any position.
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D002246 Carbon Disulfide A colorless, flammable, poisonous liquid, CS2. It is used as a solvent, and is a counterirritant and has local anesthetic properties but is not used as such. It is highly toxic with pronounced CNS, hematologic, and dermatologic effects. Disulfide, Carbon
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004050 Ditiocarb A chelating agent that has been used to mobilize toxic metals from the tissues of humans and experimental animals. It is the main metabolite of DISULFIRAM. Diethyldithiocarbamate,Diethylcarbamodithioic Acid,Diethyldithiocarbamic Acid,Dithiocarb,Ditiocarb Sodium,Ditiocarb, Ammonium Salt,Ditiocarb, Bismuth Salt,Ditiocarb, Lead Salt,Ditiocarb, Potassium Salt,Ditiocarb, Sodium Salt,Ditiocarb, Sodium Salt, Trihydrate,Ditiocarb, Tin(4+) Salt,Ditiocarb, Zinc Salt,Imuthiol,Sodium Diethyldithiocarbamate,Thiocarb,Zinc Diethyldithiocarbamate,Ammonium Salt Ditiocarb,Bismuth Salt Ditiocarb,Diethyldithiocarbamate, Sodium,Diethyldithiocarbamate, Zinc,Lead Salt Ditiocarb,Potassium Salt Ditiocarb,Sodium Salt Ditiocarb,Sodium, Ditiocarb,Zinc Salt Ditiocarb
D004127 Dimethylhydrazines Hydrazines substituted with two methyl groups in any position. Dimethylhydrazine

Related Publications

M Moriya, and T Ohta, and K Watanabe, and Y Watanabe, and F Sugiyama, and T Miyazawa, and Y Shirasu
November 1977, Cancer,
M Moriya, and T Ohta, and K Watanabe, and Y Watanabe, and F Sugiyama, and T Miyazawa, and Y Shirasu
October 1986, Cancer research,
M Moriya, and T Ohta, and K Watanabe, and Y Watanabe, and F Sugiyama, and T Miyazawa, and Y Shirasu
January 2020, Mutation research. Genetic toxicology and environmental mutagenesis,
M Moriya, and T Ohta, and K Watanabe, and Y Watanabe, and F Sugiyama, and T Miyazawa, and Y Shirasu
August 1976, Cancer research,
M Moriya, and T Ohta, and K Watanabe, and Y Watanabe, and F Sugiyama, and T Miyazawa, and Y Shirasu
January 2011, Journal of biomedicine & biotechnology,
M Moriya, and T Ohta, and K Watanabe, and Y Watanabe, and F Sugiyama, and T Miyazawa, and Y Shirasu
May 1996, Mutagenesis,
M Moriya, and T Ohta, and K Watanabe, and Y Watanabe, and F Sugiyama, and T Miyazawa, and Y Shirasu
January 1982, Cancer letters,
M Moriya, and T Ohta, and K Watanabe, and Y Watanabe, and F Sugiyama, and T Miyazawa, and Y Shirasu
February 1975, Cancer research,
M Moriya, and T Ohta, and K Watanabe, and Y Watanabe, and F Sugiyama, and T Miyazawa, and Y Shirasu
June 1991, Carcinogenesis,
M Moriya, and T Ohta, and K Watanabe, and Y Watanabe, and F Sugiyama, and T Miyazawa, and Y Shirasu
November 2004, Mutation research,
Copied contents to your clipboard!